Researcher
Evelyne Meyer
- Disciplines:Veterinary microbiology, Veterinary physiology, pathophysiology and biochemistry
Affiliations
- Department of Veterinary and Biosciences (Department)
Member
From1 Oct 2021 → Today - Department of Pharmacology, Toxicology and Biochemistry (Department)
Member
From10 Oct 2005 → 30 Sep 2021 - Department of Comparative physiology and biometrics (Department)
Member
From1 Feb 1999 → 9 Oct 2005 - Department of Bio-analysis (Department)
Member
From1 Jan 1993 → 31 Jan 1999
Projects
1 - 10 of 17
- Spontaneous B-cell lymphoma in dogs: state-of-the-art immunophenotyping and proof of concept on immunotherapeutic targets to benefit canine patientsFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Exploring co-encapsulation of antihistamines and immune checkpoint siRNAs in lipid nanoparticles for cancer immunotherapy.From1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Triple Negative Breast Cancer, Immunotherapy, Tumor microenvironment, Patient selection, Cancer Associated Fibroblasts, Preclinical ModelsFrom1 Dec 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Spontaneous B cell lymphoma in dogs: state-of-the-art immunophenotyping and proof-of-concept on immunotherapeutic targets to benefit canine patientsFrom14 Nov 2022 → 31 Oct 2023Funding: BOF - doctoral mandates
- Cofunding core facility - Flow cytometryFrom1 Nov 2022 → TodayFunding: BOF - research organisations
- Engineered lysines as innovative antimicrobial strategy for the treatment of coliform mastitisFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- A pipeline for phage lysins targeting multidrug-resistant Staphylococcus pseudintermedius in canine pyoderma and bacterial otitis externaFrom15 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Modular high-end mass spectrometer for ultrasensitive quantification and imaging of small organic molecules in cross-health research - MSsmall-XHFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Chitinase 3-like 1 as novel immunotherapeutic target in triple-negative breast cancerFrom1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- RT 20/4 ALTERTOX - Towards risk assessment of Alternaria mycotoxins: comparative in vitro toxicity, and in vivo toxicokinetics in pigs as surrogate animal model for humansFrom1 Sep 2020 → 31 Aug 2022Funding: Ministery of Social Affairs, Public Health and Environment
Publications
1 - 10 of 47
- Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis(2024)
Authors: Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
- Viability and function dynamics of circulating versus endometrial polymorphonuclear leukocytes in postpartum dairy cows with subclinical or clinical endometritis(2023)
Authors: Leen Lietaer, Osvaldo Américo Bogado Pascottini, Stijn Heirbaut, Kristel Demeyere, Leen Vandaele, Evelyne Meyer, Veerle Fievez, Jo Leroy, Geert Opsomer
Pages: 3436 - 3447 - Potential of urine biomarkers CHI3L1, NGAL, TIMP-2, IGFBP7, and combinations as complementary diagnostic tools for acute kidney injury after pediatric cardiac surgery : a prospective cohort study(2023)
Authors: Wim Vandenberghe, Jorien De Loor, Katrien Francois, Kristof Vandekerckhove, INGRID HERCK, Johan Vande Walle, Harlinde Peperstraete, Thierry Bové, Daniël De Wolf, Lieve Nuytinck, et al.
- Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer : proof-of-principle(2023)
Authors: Jonas Steenbrugge, Glenn Pauwelyn, Kristel Demeyere, Nausikaa Devriendt, Hilde De Rooster, Niek Sanders, Jan H. Spaas, Evelyne Meyer, Sina Naserian
- Development of engineered endolysins with in vitro intracellular activity against streptococcal bovine mastitis‐causing pathogens(2023)
Authors: Niels Vander Elst, Joni Bert, Herman Favoreel, Rob Lavigne, Evelyne Meyer, Yves Briers
Pages: 2367 - 2386 - Priming of the murine mammary gland with Staphylococcus chromogenes IM reduces bacterial growth of Streptococcus uberis : a proof-of-concept study(2023)
Authors: Niels Vander Elst, Julie Bellemans, Jonas Steenbrugge, Chloë Geeroms, Koen Breyne, Sofie Piepers, Bruno Toledo Silva, Fernando Nogueira De Souza, Freddy Haesebrouck, Sarne De Vliegher, et al.
- Oral supplementation with yeast beta-glucans improves the resolution of Escherichia coli-associated inflammatory responses independently of monocyte/macrophage immune training(2022)
Authors: Sarah Walachowski, Koen Breyne, Thomas Secher, Celine Cougoule, Laurence Guzylack-Piriou, Evelyne Meyer, Gilles Foucras, Guillaume Tabouret
- Different local, innate and adaptive immune responses are induced by two commercial Mycoplasma hyopneumoniae bacterins and an adjuvant alone(2022)
Authors: Lisa Beuckelaere, Maarten Haspeslagh, Evelien Biebaut, Filip Boyen, Freddy Haesebrouck, Roman Krejci, Evelyne Meyer, David Gleerup, Ward De Spiegelaere, Bert Devriendt, et al.
- A bacterial mixed culture is capable of degrading the mycotoxin deoxynivalenol into a metabolite, which still has a high toxic effect towards eukaryotic cells(2021)
Authors: Ilse Vanhoutte, Caroline De Tender, Kristel Demeyere, Mohamed Fathi Abdallah Abdelmohsen, Sarah Ommeslag, Pieter Vermeir, Sarah De Saeger, Jane Debode, Evelyne Meyer, Kris Audenaert, et al.
Number of pages: 1 - Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer(2021)
Authors: Jonas Steenbrugge, Niels Vander Elst, Kristel Demeyere, Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera, Evelyne Meyer
Number of pages: 1